Sheen Derek, Weston Dequan, Gordin Eli
Department of Otolaryngology-Head and Neck Surgery UT Southwestern Medical Center (UTSW) Dallas Texas USA.
OTO Open. 2025 Jan 7;9(1):e70063. doi: 10.1002/oto2.70063. eCollection 2025 Jan-Mar.
Evaluate the feasibility of the midface degloving approach (MDA) in total maxillectomy without orbital exenteration (TMWOE) and reconstruction for sino-nasal neoplasms.
Retrospective case series.
Tertiary referral center.
This single-center series included 9 consecutive sino-nasal neoplasm patients who had TMWOE using MDA, free tissue reconstruction, and orbital floor implants (April 2018-Dec 2022) assessing tumor characteristics, margins, and complications.
There were 3 female and 6 male patients with a median age of 61 years. The median follow-up was 462 days. There were 7 malignant and 2 benign tumors. The median tumor size was 4.6 cm. There were 7 clear margins and 2 positive margins. Most patients underwent some combination of preoperative and or postoperative therapies. After resection, a variety of free tissue reconstruction was performed. Overall, there were no complications clearly attributable to the midface degloving approach. Flap debulking was required in one patient but no long-term complications were encountered.
Midface degloving offers an alternative to the Weber-Ferguson for TMWOE and avoids facial incision while providing adequate exposure to the orbital rim. Patient selection is critical, as tumors extending laterally into the zygomatic arch and infratemporal fossa may not be accessible.
评估面中部脱套入路(MDA)在不进行眶内容物剜除术的全上颌骨切除术(TMWOE)及鼻窦肿瘤重建中的可行性。
回顾性病例系列。
三级转诊中心。
该单中心系列研究纳入了9例连续的鼻窦肿瘤患者,这些患者在2018年4月至2022年12月期间采用MDA进行了TMWOE、游离组织重建和眶底植入物,评估肿瘤特征、切缘和并发症。
有3例女性和6例男性患者,中位年龄为61岁。中位随访时间为462天。有7例恶性肿瘤和2例良性肿瘤。中位肿瘤大小为4.6厘米。有7例切缘阴性和2例切缘阳性。大多数患者接受了术前和/或术后治疗的某种组合。切除后,进行了多种游离组织重建。总体而言,没有明显归因于面中部脱套入路的并发症。1例患者需要进行皮瓣减容,但未遇到长期并发症。
面中部脱套入路为TMWOE提供了一种替代Weber-Ferguson入路的方法,避免了面部切口,同时能充分暴露眶缘。患者选择至关重要,因为向外侧延伸至颧弓和颞下窝的肿瘤可能无法通过该入路切除。